TOKYO, Mar 25 (Pulse News Wire) – SymBio Pharmaceuticals Limited (4582.T) announced that its annual shareholders meeting held on March 24 approved key resolutions, including amendments to the articles of incorporation and the appointment of directors and audit committee members. All proposals received more than two-thirds approval from eligible voters through pre-meeting proxy votes and internet voting, along with those attending the meeting.
The meeting approved increasing the total number of shares the company can issue to facilitate future expansion and fund-raising efforts. Additionally, five non-audit committee directors—representatives such as Yoshida Fumiki, Bruce David Cheson, George Mostyn, Ralph Smolling, and Nomura Hiroshi—were appointed. Three audit committee directors—Shimomura Tsunehito, Mizutani Eisaku, and Ichinozawa Takeshi—and one alternate audit committee director, Endo Koushikichi, also received approval.
Detailed vote counts showed strong support across all resolutions. For instance, the proposal to amend the articles of incorporation garnered 90.61% approval, while the selection of individual directors achieved approval rates ranging from 92.65% to 92.85%. The company did not include some outstanding votes due to incomplete confirmation data but confirmed sufficient support to pass all motions without their inclusion.
🟢 Confidence: High AI-translated content.